Home / Community / News / News

News

10/16/2018 - 8:26am

A new study lends support for a DM biomarker panel based upon patient urine exRNA assays that may serve as a pharmacodynamic biomarker for go/no go decisions in drug development for DM1.

10/16/2018 - 8:19am

A new review looks at the cross-disease evidence for RAN translation’s contributions to pathogenesis.

09/25/2018 - 12:03pm

MDF is pleased to announce the publication of the first-ever Consensus-based Care Recommendations for Adults with Myotonic Dystrophy Type 1.

09/25/2018 - 11:38am

Publication of a new systematic review provides insights into clinical outcome measures for DM2.

09/25/2018 - 11:30am

Induced pluripotential stem cells (iPSCs) from DM2 provide new tools for CNS-focused mechanistic and translational studies.

Partners

ExpansionTherapeutics.png

© Myotonic Dystrophy Foundation. All rights reserved.